#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Clinicians treating older adults need to understand cannabis-related cardiovascular risks, as this population already has high baseline rates of heart disease and takes multiple medications with potential drug interactions. Patients over 65 considering cannabis for pain, sleep, or other conditions should have informed discussions with their providers about these age-specific safety concerns before use. Evidence-based guidance on cannabis use in older adults enables clinicians to provide appropriate counseling and monitoring for a growing demographic interested in this treatment option.
Cannabis use in older adults presents distinct safety concerns that clinicians should address during patient consultations. Emerging evidence suggests regular cannabis consumption is associated with increased cardiovascular risk, a particularly important consideration given that patients over 65 already carry baseline cardiovascular disease burden. Stanford researchers highlight additional risks specific to aging populations, including cognitive effects, fall risk from impaired balance and coordination, and potential drug-drug interactions with common geriatric medications. The limited regulatory oversight and heterogeneous product composition in cannabis markets means older patients may receive inconsistent dosing and potency, complicating safe prescribing guidance. Clinicians caring for elderly patients should conduct detailed substance use assessments and counsel patients about cardiovascular and fall risks before cannabis use, especially those with existing hypertension, coronary artery disease, or mobility concerns. When discussing cannabis with older patients, physicians should emphasize that despite growing legalization, safety data in this population remains incomplete, and individual risk stratification should guide whether use is appropriate.
“We know cannabis affects cardiovascular hemodynamics in measurable ways, and when you’re managing a 70-year-old with hypertension or existing heart disease, you can’t ignore that interaction the way we might with a younger, healthier patient, so I screen carefully and often recommend against it or suggest very low-dose, non-smoked alternatives if the clinical benefit seems genuine.”
🫀 As cannabis use becomes increasingly normalized and legally accessible, clinicians caring for older adults should be aware that emerging evidence suggests regular cannabis consumption may be associated with cardiovascular risks including myocardial infarction, arrhythmias, and stroke—concerns particularly relevant given the high baseline cardiovascular disease burden in patients over 65. However, most supporting studies are observational or conducted in younger populations, making it difficult to establish causality or quantify absolute risk in older cohorts, and confounding factors such as concurrent smoking, underlying comorbidities, and specific cannabis preparation methods complicate interpretation. Additionally, older patients may use cannabis for legitimate indications such as chronic pain or chemotherapy-induced nausea, and abrupt discontinuation could worsen quality of life or medication adherence. Clinicians should engage in candid, nonjudgmental discussion with older patients about cannabis use patterns, screen for cardiovascular symptoms and medication interactions,
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
